You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Integrated Platform for Mass-Spectrometric Studies of Protein Structure
SBC: PROTEIN METRICS INC Topic: 400Summary Technology for studying the higher order structure (HOS) and interactions of biomolecules is a highlighted NIGMS SBIR/STTR research topic. Mass-spectrometric methods for studying HOS include hydroxyl radical footprinting as well as chemical methods to covalently label amino acid side-chain functional groups, and also hydrogen/deuterium exchange (HDX) on protein backbone amides. These metho ...
STTR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
Clinical Text Automatic De-Identification to Support Large Scale Data Reuse and Sharing
SBC: Clinacuity, Inc Topic: 400The adoption of Electronic Health Record (EHR) systems is growing at a fast pace in the U.S., and this growth results in very large quantities of patient clinical data becoming available in electronic format with tremendous potential but an equally large concern for patient confidentiality breaches. Secondary use of clinical data is essential to fulfill the potential for high quality healthcare, i ...
STTR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
Development of novel Amadorins for Diabetic Peripheral Neuropathy
SBC: Praetego Inc Topic: 200PROJECT SUMMARY Diabetic peripheral neuropathy (DPN) is the most common diabetic complication. DPN is a leading cause for disability due to foot ulceration and amputation, gait disturbance, and fall-related injury. There is no FDA- approved disease modifying treatment for DPN, a condition affecting up to 50% of the estimated 30 million diabetic patients in the US. Neuropathy occurs in patients wit ...
STTR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
Therapeutic inhibition of Fas-mediated retinal cell death and inflammation in dry AMD
SBC: ONL Therapeutics, Inc. Topic: NEIPROJECT SUMMARY / ABSTRACT Age-related macular degeneration (AMD) is the leading, and due to the aging baby boomers, a growing cause of irreversible vision loss in the United States, and is strongly associated with exposure to cigarette smoke (CS) and high fat diets (HFD). While effective treatment is available for neovascular AMD, the AREDS II antioxidant vitamins are the only proven treatment fo ...
STTR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
Image Analysis Tools for mpMRI Prostate Cancer Diagnosis Using PI-RADS
SBC: Eigen Health Services LLC Topic: 102Project Summary Prostate cancer is one of the most commonly occurring forms of cancer, accounting for 21% of all cancer in men. The Prostate Imaging Reporting and Data System (PI-RADS) aims to standardize reporting of prostate cancer using multi-parametric magnetic resonance imaging (mpMRI). However, the in-depth analysis, as demanded by PI-RADS, remains challenging due to the complexity and heter ...
STTR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
InheRET: A SaaS solution to identify patients at increased risk for hereditary disease.
SBC: Inheret, Inc Topic: 102PROJECT SUMMARY This project is to expand the InheRET Inherited Risk Evaluation Tool to include recommendations for testing of patients at increased risk for hereditary disease, adding patient navigation features and customizable database entries for healthcare providers. This will include the development, integration and testing of InheRET 3.0 followed by pilot testing in 5 diverse clinics. InheR ...
STTR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
Algorithms for Look-down Infrared Target Exploitation
SBC: SIGNATURE RESEARCH, INC. Topic: NGA18A001The multidisciplinary area of GEOINT is changing and becoming more complex. A major driver of innovation in GEOINT collection and processing is artificial intelligence (AI). AI is being leveraged to help accomplish spatial analysis, change detection, and image or video triage tasks where filtering objects of interest from large volumes of data is critical. NGA is confronting the changing GEOINT l ...
STTR Phase II 2020 Department of DefenseNational Geospatial-Intelligence Agency -
Low Visibility Radio Frequency Resonator
SBC: VIRTUAL EM INC. Topic: SOCOM19A001A prototyping effort is being proposed to develop methods and tools for utilizing structures of opportunity as efficient radiations in the HF, VHF and UHF bands.
STTR Phase II 2020 Department of DefenseSpecial Operations Command -
A Method to Increase Buprenorphine Treatment Capacity and Effectiveness
SBC: CBT4CBT LLC Topic: R42The goal of this fast track STTR proposal is to expand buprenorphine maintenance therapy for opioiddependent patientsOvermillion people in the US are addicted to opiatesProviding effective agonist therapymethadone or buprenorphinecoupled with behavioral counseling greatly improves outcomesreduces morbidityand reduces societal costsMethadone maintenance treatment has been limited due to complex sta ...
STTR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Testing a male oral contraceptive targeting Eppin
SBC: EPPIN PHARMA INC Topic: NICHDThe global contraceptives market was valued at $billion inand is expected to grow at a CAGR offromtoto reach an estimated value of $billion inThe contraceptive market consists of short term methods such as condoms and oral contraceptionlong term methods including implants and IUDsand permanent methods such as tubal ligations and vasectomiesEppin Pharmaandapos s product has a unique set of characte ...
STTR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health